Unknown PHASE4 INTERVENTIONAL 2-arm NCT01798875

PCOS, Therapy and Markers of Cardiovascular Risk

Effects of Different Therapies on Surrogate Markers of Cardiovascular Risk in Women With Polycystic Ovary Syndrome (PCOS)

Sponsor: Medical University of Gdansk

Conditions PCOS

Interventions oral contraceptive oral metformin

Updated 5 times since 2017 Last updated: Feb 28, 2013 Started: Apr 30, 2012 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates PCOS and is currently ongoing. Medical University of Gdansk leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Gdansk

Data source: Medical University of Gdansk

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gdansk, Poland